Chemomab Therapeutics Ltd. (CMMB) › Shareholders' EquityChemomab Therapeutics Ltd. (CMMB) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$609.0K2018: $9.80M2019: $12.37M2020: $10.80M2021: $61.47M2022: $36.22M2023: $17.00M2024: $13.54M2025: $12.33M$12.33M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$12.33M-8.9%2024$13.54M-20.4%2023$17.00M-53.1%2022$36.22M-41.1%2021$61.47M+469.0%2020$10.80M-12.7%2019$12.37M+26.2%2018$9.80M+1710.0%2017-$609.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share